Mixed response to turbine proposals

THE long-term “economic competitiveness” of GlaxoSmithKline (GSK) Montrose will be supported by the addition of wind turbines to its local factory, the site’s director has said.

Addressing a public meeting in the academy on Thursday night, Andrew Ross told the 100-plus audience that the “green credentials” the project - to site two 426-metre high turbines at the Cobden Street facility - would bring to the factory would help it stand out both globally and within the company itself.

The meeting was organised by Montrose Community Council to give the public a say on the company’s scheme and to allow it to gauge opinion and formulate a formal response to GSK’s planning application, which was submitted to Angus Council in December.

Read the full report in this week’s Review.